Description: NanoEnTek Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a quantitative fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, an analytical device for counting the residual white blood cells; ADAMII, a fluorescence stem cell counter; EVE, a benchtop counter to measure cell count and viability; Arthur/fluorescence cell counters; automated somatic cell counters; live-cell imaging system; and disposable hemocytometers. The company was founded in 2000 and is headquartered in Seoul, South Korea.
Home Page: www.nanoentek.com
5, Digital-ro 26-gil
Seoul,
08389
South Korea
Phone:
82 2 6220 7728
Officers
| Name | Title |
|---|---|
| Mr. Jin-Hyung Park | Chief Exec. Officer and Director |
| Mr. Han-Sang Cho | Sr. Managing Director |
| Mr. Chan-Il Jeong | Sr. Managing Director |
| Mr. Hee-Don An | Managing Director |
| Ms. Sun-Mee Han | Managing Director |
| Mr. Jung-Goo Seo | Vice-Pres and Director |
Exchange: KQ
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 3.5463 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 127 |